Answers are grounded in this paper and cite their sources.
The rapid expansion of digital health technologies, including mobile health (mHealth) apps, wearable technologies, and telemedicine, is revolutionizing chronic disease management. The technologies enable remote monitoring, personalized treatment strategies, and increased patient activation, particularly for diabetes, hypertension, cardiovascular diseases, chronic respiratory diseases, cancer, and mental disorders such as major depressive disorder and anxiety. Evidence confirms that mHealth interventions facilitate glycemic control in diabetes, enhance blood pressure management, rationalize asthma and COPD management, facilitate remote oncology consultations, and facilitate digital cognitive behavior therapy for mental disorders. Despite these advantages, there are disadvantages in the form of digital literacy gaps, inadequate access among disadvantaged groups, data privacy concerns, and regulatory diversity. Excessive implementation costs and demands for clinical evidence also are major constraints to global application. Emerging advancements in artificial intelligence, machine learning, and digital interoperability will also enhance the ability of digital health to predict at an earlier time and in a more personalized way. Closing the digital divide through enhanced accessibility, regulatory settings, and cross-sector collaborations is necessary to enable equal sharing of benefits from digital health. The review addresses the effectiveness of digital health interventions in the management of chronic diseases, drawing attention to innovation, challenges, and directions ahead.
No takes yet. Share an insight, caveat, or question.
Manaswi Chigurupati (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: